FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 0472-1915 · HUMAN PRESCRIPTION DRUG · SUPPOSITORY

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205654
Dosage form / routeSUPPOSITORY · RECTAL
Active ingredientsMESALAMINE (1000 mg/1)
Marketing started20210423
Marketing ended20261130
Package count1

External sources

Source: openFDA. Public-domain (CC0).